skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

27 Total results for product and free and sample content found

Biomedtracker

BMT Q4 Outlook Report

27 Oct 2017

In this report, we cover catalysts from 21 drugs expected to occur in Q4 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Alzheimers Cancer Drug approval

Pharmaprojects

Building something great: UK's Global Bioscience Cluster 2016

10 Oct 2017

The UK has some of the world’s most exciting science, a supportive business environment, and strong companies led by experienced management teams.

Topic BioPharmaceutical

Medtrack

Partnering in the Pharma World

25 Sep 2017

The 23rd Annual International Partnering Conference, Bio Europe 2017, November 6 – 8, in Berlin, Germany is fast approaching. Via one-on-one partnering meetings, attendees over the world from all facets of biotech will meet at Europe’s largest life science partnering conference to identify, engage with, and enter into strategic relationships to drive their business forward.

Topic Clinical trials

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 19 Sep 2017

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deal trends

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 19 Sep 2017

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Medtrack

Maximizing Royalty Rate Opportunities in Pharma Licensing

By Steven Muntner 16 Sep 2017

Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.

Topic Deal trends Medtech

Datamonitor Healthcare

Big Pharma Outlook 2026 Pharmavitae Analytics Report Extract

05 Aug 2017

Big Pharma Outlook 2026 takes decade-long look at what’s in store for the future of Big Pharma.

Biomedtracker

Report Extract: Q3 2017 Outlook Report

17 Jul 2017

In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Alzheimers Cancer Drug approval

Strategic Transactions, Scrip

Building something great: UK's Global Bioscience Cluster 2016

22 May 2017

Featured recently in The Telegraph and The Times, Building something great: UK’s Global Bioscience Cluster 2016, the pivotal report from Informa Pharma Intelligence and The UK BioIndustry Association, is now available to you in its entirety as a free download.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: